AbCellera.
company in Vancouver, Canada
- Reports this week
- 0
- Active events
- 0
- Connections
- 38
What's happening
One to three months ago
-
AbCellera, a company, is based in Vancouver, British Columbia.Well supported11 reports
-
An FDA decision influenced AbCellera's stock climb, related to the company's work advancing immune treatments.Some support1 report
-
Vertex and AbCellera are collaborating to advance T cell therapies (TCEs) for autoimmune diseases.Some support2 reports1 development inside
-
AbCellera announced that its Phase II clinical trial data exceeded expectations for blockbuster potential on August 11, 2026.Some support1 report
-
AbCellera debuted on the Nasdaq stock exchange on August 4, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Competitors acquired companies involved in the same market, and Lynn Seely was appointed to the company's Board of Directors.Some support1 report
-
Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.Some support3 reports
-
Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.Well supported4 reports
-
AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.Some support1 report
-
AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.Speculative1 report
-
Leerink Partners affirmed an Outperform rating on AbCellera.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around AbCellera this week
News at the entities that move AbCellera most-
FDA StructuralBMS, Eli Lilly, and Novo Nordisk are advancing GLP-1 portfolios, investing in manufacturing, and navigating regulatory approvals.Moves AbCellera
-
Vertex OperationalA Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.Moves AbCellera
-
Sanofi OperationalSanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.Moves AbCellera
-
Benchmark TransactionalPrudential expands its partnership with SoFi, while Benchmark upgrades SoFi's stock rating to Strong Buy.Moves AbCellera
-
British Columbia Shared contextThe new event mentions Idaho and British Columbia without providing any details about what happened.Moves AbCellera
-
investing.com Mentioned togetherGildan Activewear experienced a stock fall, as reported by investing.com on June 19, 2026.Moves AbCellera
Connections
The 13 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Bruker Structural
AbCellera is linked to Bruker via a subsidiary relationship, while also being involved in patent infringement litigation.
-
Jazz Pharmaceuticals Operational
The companies maintain an active partnership focused on joint collaboration and development of multispecific antibodies.
-
Vertex Operational
The companies are engaged in a strategic collaboration to develop Targeted Cell Engagements (TCEs) for autoimmune diseases.
-
FDA Structural
The FDA functions as the primary regulatory body whose decisions govern the market viability and operational status of AbCellera.
-
Sanofi Operational
The entities are competitors operating in the same market, driven by market acquisitions and consolidation.
-
Benchmark Transactional
Benchmark upgraded AbCellera's stock rating.
-
investing.com Mentioned together
investing.com reports on AbCellera's financial performance.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald has provided investment coverage and research reports on AbCellera.
Show all 13 connections
-
Rio de Janeiro Shared context
AbCellera is temporarily located in Rio de Janeiro to present data at a conference.
-
British Columbia Shared context
AbCellera operates and is headquartered in British Columbia.
-
TMS Operational
AbCellera presented data at a meeting hosted by TMS.
-
Nasdaq Shared context
AbCellera is a company whose shares are listed and trade on the Nasdaq stock exchange.
-
Vancouver Shared context
AbCellera is headquartered and conducts business operations from its base in Vancouver, British Columbia.
History
Events by the month they beganOctober 2026
1 eventAugust 2026
4 events- An FDA decision influenced AbCellera's stock climb, related to the company's work advancing immune treatments.
- Vertex and AbCellera are collaborating to advance T cell therapies (TCEs) for autoimmune diseases.
- AbCellera announced that its Phase II clinical trial data exceeded expectations for blockbuster potential on August 11, 2026.
- AbCellera debuted on the Nasdaq stock exchange on August 4, 2026.
July 2026
1 eventShow 1 earlier month
June 2026
6 events- AbCellera, a company, is based in Vancouver, British Columbia.
- Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
- Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.
- AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.
- AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.
- Leerink Partners affirmed an Outperform rating on AbCellera.